Insights (2)

With three COVID-19 vaccines approved under Emergency Use Authorization (EUA), what is the latest regarding additional vaccine approvals? Let us look ...

Introduction Cancer is the second most common cause of death in the US1, and one of the most feared. Its effects can be devastating–physically, emotio...

Questions you should ask to assess the robustness of your medical benefit specialty drug management program

Managing the costs of a rare and complex disease What is Hemophilia A? Hemophilia A is a rare, chronic, inherited disease that occurs in about 1 of ev...

In 2019, Katherine Eban published a book, “Bottle of Lies”. It tells a convincing story that leaves readers concluding that all generic drugs are bad....

What is PrEP PrEP is short for Pre-Exposure Prophylaxis and is used as a preventative medication of HIV infection. The virus-killing medication is tak...

*Co-Authors: Sharon Montgomery, BSPharm, MA, RPh, Principal Advisor Thatcher Sloan, Vice President, Practice Leader Ruth Opdycke, PharmD, MS, Principa...

The Race To A New Normal: A COVID-19 Vaccine Pipeline Update The medical community has been feverishly working toward a COVID-19 vaccine and we are no...

*Co-Authored By: Thatcher Sloan, Vice President, Practice Leader What You Need to Know

Positioning themselves for continued growth in 2021 and beyond [TOWSON, Maryland: October 2, 2020] – Confidio, a technology-enabled pharmacy benefits ...

Diving deep into the drug trends driven by COVID-19 provides insight on the impact shelter-in-place may have on the future of healthcare. It also prov...

What Plan Sponsors Need To Know On July 24th, President Trump signed four executive orders aimed at lowering drug prices in the US. The orders focus o...